But, patients will only need one dose of the drug.
The drug has now been recommended for use by the NHS for all patients who require oxygen from as early as next week.
Tocilizumab will likely be used alongside the steroid Dexamethasone, which is already approved for use in coronavirus patients.
Peter Horby, professor of emerging infectious diseases in the Nuffield Department of Medicine, University of Oxford, and joint chief investigator for Recovery, said: “Previous trials of Tocilizumab had shown mixed results, and it was unclear which patients might benefit from the treatment.
Published at Thu, 11 Feb 2021 20:07:24 +0000